Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-08-10 PFIZER INC 10% owner Sale −9,901 $37.23 $369K 1,183,640
2015-08-10 PFIZER INC 10% owner Sale −10,544 $36.37 $383K 1,173,096
2015-08-10 PFIZER INC 10% owner Sale −11,627 $38.49 $448K 1,161,469
2015-08-10 PFIZER INC 10% owner Sale −12,726 $25.32 $322K 1,148,743
2015-08-10 PFIZER INC 10% owner Sale −13,109 $26.32 $345K 1,135,634
2015-08-10 PFIZER INC 10% owner Sale −25,931 $20.35 $528K 1,109,703
2015-08-10 PFIZER INC 10% owner Sale −31,400 $24.31 $763K 1,078,303
2015-08-10 PFIZER INC 10% owner Sale −44,268 $22.60 $1.0M 1,034,035
2015-08-10 PFIZER INC 10% owner Sale −58,632 $23.41 $1.4M 975,403
2015-08-10 JOHNSON & JOHNSON 10% owner Sale −231,455 $31.66 $7.3M 1,383,366
2015-03-12 SIMPSON TODD E Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2015-03-12 SHREWSBURY STEPHEN B CMO; Senior VP Clinical Dev. Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-03-12 Pelzer Robert Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2015-03-12 Nolan Sean P. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2015-03-12 Main David President and CEO Grant or award · Stock Option (Right to Buy) +65,000 65,000
2015-03-12 MacKenzie Lloyd VP Technical Operations Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-03-12 LEVITT DANIEL J Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2015-03-12 Bridger Gary Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2015-03-12 Alam Kamran CFO, Vice President Finance Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-01-11 Mitchell David Chilton VP Global Regulatory & Quality Grant or award · Stock Option (Right to Buy) +35,000 35,000

Page 22 of 27 · 537 trades